Catalyst Wire Dossier Catalyst Wire Dossier

Vgenfli

aflibercept · Zaklady Farmaceutyczne Polpharma S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vgenfli, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: EMA Authorised: Vgenfli (aflibercept) — Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

See pricing